There are 2867 resources available
Invited Discussant 451O, 452O and 453O
Presenter: Philippe Cassier
Session: Proffered Paper session: Developmental therapeutics
Resources:
Slides
Webcast
The use of biomarkers in de-escalation
Presenter: Albrecht Stenzinger
Session: De-escalation of treatment in medical oncology
Resources:
Slides
Webcast
CN13 - Nutriscore: Nutritional screening in colorectal cancer patients previous to cancer-specific treatment
Presenter: Raquel Legido-Diaz
Session: Health promotion, prevention, and screening
Resources:
Abstract
658MO - Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040
Presenter: Denis Soulieres
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
1735O - PD-L1 expression on immune cells by SP142 co-localises with dendritic cells and is associated with improved overall survival (OS) with atezolizumab in patients with untreated metastatic urothelial cancer (mUC)
Presenter: Enrique Grande Pulido
Session: Proffered Paper session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
1485O - Percutaneous uterine needle biopsy with microscopic and array-CGH analyses in patients with suspicious myometrial tumors on MRI: A prospective study
Presenter: Jeremy SMADJA
Session: Proffered Paper session: Sarcoma
Resources:
Abstract
Slides
Webcast
LBA14 - Impact of age, recurrence score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials
Presenter: Oleg Gluz
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
The role of KRAS inhibitor and other new treatment options in pancreatic cancer
Presenter: Eileen O'Reilly
Session: Lessons learned and new horizons and other hepatobiliary/pancreatic malignancies
Resources:
Slides
Webcast
How to target invisible melanoma cells
Presenter: Caroline Robert
Session: Is heterogeneity the limitation of precision oncology in melanoma?
Resources:
Slides
Webcast
Where does IO fit in?
Presenter: Rina Hui
Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC
Resources:
Slides
Webcast